Announcement

1
MAY
2019


Category Label


Client Announcements

Osirium Technologies : Launch of secure IT Process Automation solution

  •  
  •   01 May 2019

RNS Number : 6537X

Osirium Technologies PLC

01 May 2019

 

 

 

For immediate release

1 May 2019

 

Osirium Technologies plc

 

("Osirium" or "Group")

 

Opus sets new benchmark in Privileged IT Process Automation

 

Osirium launches first secure solution to automate key IT processes and increase IT Service Desk productivity, while also improving corporate security

 

Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, today announces the immediate availability of Opus, its secure IT Process Automation solution.   

 

Opus builds on Osirium's proven success in Privileged Task Automation, providing a highly-flexible platform for automating essential IT processes.  The product has been designed to address currently unresolved challenges of overloaded IT teams, growing backlogs of customer requests and increasing needs to improve security.

 

David Guyatt, Chief Executive Officer of Osirium commented: "Traditional ways of automating IT processes are inflexible, risky and not fit for the security-conscious 21st century IT organisation.   IT Operations teams need a much better alternative, built from the ground-up to be fully secure and integrated for simple deployment and rapid speed to value.  They want the benefits of Robotic Process Automation, but with enterprise-grade security.  Opus delivers this by automating processes and controlling access to privileged accounts, addressing one of most critical enterprise security challenges facing CISOs, to remove uneccessary direct access to vulnerable privileged accounts. 

 

"Initial customer projects are focusing on IT Help Desks, principally transforming first call resolution performance by delegating help desk automation tasks to first line support teams - a practice now known as "shift-left" operations.  Looking further ahead, Osirium sees clear scope for automating additional process-driven environments, such as NetOps, DevOps and IoT.

 

"The Directors believe that the Opus product will contribute to a growing and material impact on Osirium's financial performance."

 

- Ends -

 

For further information:

Osirium Technologies plc

Tel: +44 (0) 118 324 2444

David Guyatt, Chief Executive Officer

Rupert Hutton, Chief Financial Officer

www.osirium.com

 

 

 

 

Stifel Nicolaus Europe Limited

(Nominated Adviser and Broker)

Tel: +44 (0) 20 7710 7600

Fred Walsh / Neil Shah / Alex Price

 

 

Yellow Jersey PR

(Financial PR)

Sarah Hollins

Henry Wilkinson

 

 

Tel: +44 (0)7764 947 137

Tel: +44 (0)7951 402 336

 

 

Notes to Editors:

 

About Osirium

Osirium Technologies plc (AIM: OSI.L) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Management ("PAM") software. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.

 

Osirium has defined and delivered what the Directors view as the next generation PAM solution.  The team has developed the concept of a Virtual Air Gap to separate users from passwords.  Built on Robotic Automation technology, Osirium's Privileged Task Management module further strengthens Privileged Account security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016.  For further information please visit www.osirium.com

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

MSCKMGFDRGVGLZM

;